SeouLin Bioscience서린바이오
038070 · KOSDAQ · ₩038070 · 서린바이오
- Market cap
- ₩33B
- Enterprise value
- ₩37B
- P/E
- 36.5×
- P/B
- 0.4×
- Dividend yield
- 2.8%
- ROE
- 1.1%
- Net margin
- 1.1%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−54.7% from the high
₩3,595Today: ₩3,595 – ₩3,715₩7,940
Returns
- 1W−8.1%
- 1M−9.1%
- 3M−18.1%
- 6M−44.5%
- YTD−44.8%
- 1Y−43.8%
- Volume today
- 10,883
- 0.3× the 20-day average
- Traded today
- ₩40M
- Listed shares
- 9,300,676
- EPS (12 months)
- ₩99
- Earnings yield 2.7%
Upcoming dates
Full calendar →🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Quiet- BuzzQuietBuzz 26 of 100 (50 is a normal day for this stock).
- MomentumWeak-9.9% over the last month; the price is below its 20-day average.
- News impactLow1 news items and filings in two weeks; 0 rated high impact, 0 medium.
Signals describe activity, not recommendations. Not financial advice.
SeouLin Bioscience stock overview
SeouLin Bioscience (서린바이오, KRX: 038070) is listed on KOSDAQ, in the Retail & Trade sector. Its shares closed at ₩3,595 on Oct 26, 2026, down 2.18% on the day, giving it a market value of ₩33B.
Key facts
- Market cap
- ₩33B
- Sector
- Retail & Trade
- Latest price change
- −2.18%
- As of
- Oct 26, 2026
Quick answers about SeouLin Bioscience
- What is the market cap of SeouLin Bioscience?
- The market capitalisation of SeouLin Bioscience was ₩33B at the close on Oct 26, 2026.
- Who are the largest shareholders of SeouLin Bioscience?
- According to the latest official filings, the largest reported holders are Hwang Eul-mun (27.39%, as of Apr 2, 2026); Suseong Asset Investment (5.66%, as of Jan 13, 2026); Korea Securities Finance (4.04%, as of Apr 9, 2025).
- When is the next earnings report from SeouLin Bioscience?
- Korean companies rarely announce results dates in advance. Based on when SeouLin Bioscience filed the same report in past years, its next 3q results is expected between Nov 13, 2026 and Nov 14, 2026.
Company profile
Loading data for this company — check back soon
- Korean name
- 서린바이오
- Sector
- Retail & Trade
- CEO
- 황을문, 강미옥 (각자 대표이사)
- Founded
- Apr 1994
- Listed
- Oct 2005
- Listed shares
- 9,300,676
- Fiscal year ends
- Month 12
- Website
- www.seoulin.co.kr
Similar companies
- Samsung C&T028260 · ₩47T₩292,000+1.39%
- POSCO International047050 · ₩8.7T₩49,550−3.79%
- Youngone111770 · ₩3T₩67,400−2.32%
- ISC095340 · ₩3T₩140,600−5.19%
- Dong SUH Companies026960 · ₩2.7T₩27,300−1.44%
- SK Gas018670 · ₩2.3T₩251,000−3.09%
- Shinsegae004170 · ₩2.3T₩245,000−3.92%
- Lotte Shopping023530 · ₩2.3T₩81,400−2.63%
Recent filings
See all- Treasury share sale decisionOct 22, 2026
- Adjustment of Conversion PriceAug 13, 2026
- Half-year report (Jun 2026)Aug 13, 2026
- Quarterly report (Mar 2026)May 15, 2026
- Change of Department AffiliationApr 30, 2026
Titles in Korean until English translations are added.
Also known as: SeouLin Bioscience / 서린바이오 / 038070 / KRX:038070
Source: KRX statistical information